Tag: Daniel Cohen

June 5, 2019

Aura Provides Update on Pharmadrug and Its European Strategy

Aura Health Inc. (CSE:BUZZ) is pleased to provide an update on its operations and corporate strategy regarding the German medical...
May 31, 2019

Aura Announces Appointment of Al Quong to Its Board of Directors

Aura Health Inc. (CSE:BUZZ) is pleased to announce the appointment of Al Quong to its board of directors, subject to...
May 17, 2019

Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug

Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has closed the previously announced (May 8,...
May 8, 2019

Aura Health CEO Daniel Cohen: European Cannabis Market a Major Opportunity

Aura Health CEO Daniel Cohen is confident his company’s progress in Israel will greatly benefit its business plans moving forward.
May 8, 2019

Aura Announces Supply Agreement With FSD Pharma & Conditions Met to Close German Acquisition

Aura Health Inc. (CSE:BUZZ) is pleased to announce a multi-year supply agreement with FSD Pharma Inc. (“FSD”) and that milestones...
May 1, 2019

Aura Signs Definitive Agreement Disposing of U.S. Cannabis Certification Clinics

Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that its wholly owned subsidiary, Green Global Properties Inc....
April 17, 2019

Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Transaction

Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has closed the second tranche of its...